A shadow economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Several experts said the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking fines, prosecution or prison.
Service Reaction and Content Removal
Based on the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.
Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.
Product Information and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.
